Literature DB >> 28669617

An increasing, potentially measles-susceptible population over time after vaccination in Korea.

Hae Ji Kang1, Young Woo Han1, Su Jin Kim1, You-Jin Kim1, A-Reum Kim1, Joo Ae Kim1, Hee-Dong Jung1, Hye Eun Eom2, Ok Park3, Sung Soon Kim4.   

Abstract

BACKGROUND: In Korea, measles occurs mainly in infants <12months of age, who are unvaccinated. In addition, vaccine populations, including adolescents and young adults, can become infected though importation. Thus, the question arises whether the current level of herd immunity in Korea is now insufficient for protecting against measles infection.
METHODS: Age-specific measles seroprevalence was evaluated by performing enzyme immunoassays and plaque reduction-neutralization tests on 3050 subjects aged 0-50years (birth cohort 1964-2014) and 480 subjects aged 2-30years (birth cohort 1984-2012).
RESULTS: The overall seropositivity and measles antibody concentrations were 71.5% and 1366mIU/mL, respectively. Progressive decline in antibody levels and seropositivity were observed over time after vaccination in infants, adolescents, and young adults. The accumulation of potentially susceptible individuals in the population was confirmed by comparing data from 2010 and 2014 seroprevalence surveys. The statistical correlation between measles incidence and measles seronegativity was determined.
CONCLUSIONS: Waning levels of measles antibodies with increasing time post-vaccination suggests that measles susceptibility is potentially increasing in Korea. This trend may be related to limitations of vaccine-induced immunity in the absence of natural boosting by the wild virus, compared to naturally acquired immunity triggered by measles infection. This study provides an important view into the current measles herd immunity in Korea.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Measles; Neutralizing antibody; Seroprevalence; Waning immunity

Mesh:

Substances:

Year:  2017        PMID: 28669617     DOI: 10.1016/j.vaccine.2017.06.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

1.  Vaccination-induced herd immunity: Successes and challenges.

Authors:  Michael L Mallory; Lisa C Lindesmith; Ralph S Baric
Journal:  J Allergy Clin Immunol       Date:  2018-05-24       Impact factor: 10.793

2.  Control of a nosocomial measles outbreak among previously vaccinated adults in a population with high vaccine coverage: Korea, 2019.

Authors:  Kyunghyun Song; Ju Mi Lee; Eun Ju Lee; Bo Ram Lee; Ji Young Choi; Jihee Yun; Se Na Lee; Mi Young Jang; Han Wool Kim; Han-Sung Kim; Song Mi Moon; Yong Kyun Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-01-09       Impact factor: 3.267

3.  Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreak.

Authors:  Ravit Bassal; Victoria Indenbaum; Rakefet Pando; Tal Levin; Eilat Shinar; Doron Amichay; Mira Barak; Anat Ben-Dor; Adina Bar Haim; Ella Mendelson; Dani Cohen; Tamy Shohat
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

4.  Seroprevalence against the measles virus after vaccination or natural infection in an adult population in Madinah, Saudi Arabia.

Authors:  Waleed H Mahallawi; Nadir A Ibrahim
Journal:  Hum Vaccin Immunother       Date:  2021-02-11       Impact factor: 3.452

5.  Complete Genome Sequence of a Genotype 2B Rubella Virus Isolated in South Korea in 2015.

Authors:  Hae Ji Kang; You-Jin Kim; Hye Min Lee; Jeong-Gu Nam; Sung Soon Kim
Journal:  Genome Announc       Date:  2017-09-21

6.  Transmission potential of modified measles during an outbreak, Japan, March‒May 2018.

Authors:  Kenji Mizumoto; Tetsuro Kobayashi; Gerardo Chowell
Journal:  Euro Surveill       Date:  2018-06

7.  Measles and rubella immunity in the population of Bhutan, 2017.

Authors:  Sonam Wangchuk; Francisco Nogareda; Namgay Tshering; Lekey Khandu; Sonam Pelden; Kathleen Wannemuehler; Sonam Wangdi; Ugyen Wangchuk; Mick Mulders; Tshewang Tamang; Minal K Patel
Journal:  Vaccine       Date:  2019-09-06       Impact factor: 3.641

Review 8.  Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease.

Authors:  Shintaro Sagami; Taku Kobayashi; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2018-07-17

9.  Measles seroprevalence among healthcare workers in South Korea during the post-elimination period.

Authors:  Seung Beom Han; Sun Hee Park; Yunmi Yi; Seul Ki Ji; So Hee Jang; Min Hee Park; Ji Eun Lee; Hye Sook Jeong; Soyoung Shin
Journal:  Hum Vaccin Immunother       Date:  2021-03-09       Impact factor: 3.452

10.  Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination.

Authors:  Chung-Jong Kim; Ji-Yun Bae; Kang-Il Jun; Hae-Sun Chung; Aeyeon Kim; Jihee Kim; Hee-Jung Son; Miae Lee; Hee-Jung Choi
Journal:  Vaccines (Basel)       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.